Apelin receptor agonists help preserve endothelial cells and capillary architecture in IPF, reducing inflammation and slowing fibrotic decline.
Compound I restores CFTR trafficking and channel activity to improve anion transport, reduce mucus buildup, and ease cystic fibrosis symptoms.
Controlled heat-drying boosts parsnip polyphenols before extraction, improving antioxidant and anti-inflammatory activity for respiratory disease care.
A deuterated CFTR modulator combined with other CFTR agents improves protein trafficking and channel activity to ease cystic fibrosis symptoms.